P63165 (SUMO1_HUMAN) Homo sapiens (Human)

Small ubiquitin-related modifier 1 UniProtKBInterProSTRINGInteractive Modelling

101 aa; Sequence (Fasta) ; (Isoform 2; ) 26 identical sequences

Molecule Processing
Small ubiquitin-related modifier 1

Sequence Features

 36Interaction with PIAS2
 22-91Rad60/SUMO-like domain
IPR022617PF11976

Sequence Alignments

Experimental structures

DescriptionOligo-stateLigandsStructureRangeDownloadAssess
Docked structure between SUMO1 and ZZ-domain from CBP Heteromer
Q92793;
ZN;2n1a1-101
Phosphorylation of SUMO-interacting motif by CK2 enhances Daxx SUMO binding activity Heteromer
Q9UER7;
2kqs1-97
SUMO E1 ACTIVATING ENZYME SAE1-SAE2-SUMO1-MG-ATP COMPLEX Heteromer
Q9UBE0; Q9UBT2;
MG;ZN;ATP;1y8r14-97
SENP1 (mutant) full length SUMO1 Heteromer
Q9P0U3;
2iy120-101
Crystal structure of K45-acetylated SUMO1 in complex with phosphorylated PML-SIM Heteromer
P29590;
SEP;6uyu19-97
Crystal Structure of SUMO1-conjugated thymine DNA glycosylase Heteromer
Q13569;
CL;MG;NA;1wyw19-97
Human SUMO E1 complex with a SUMO1-AMP mimic Heteromer
Q9UBE0; Q9UBT2;
ZN;JZU;3kyc19-97
Structure of SUMO modified Ubc9 Heteromer
P63280;
FMT;NA;2vrr20-97
Complex between human RanGAP1-SUMO1, UBC9 and the IR1 domain from RanBP2 containing IR2 Motif II Heteromer
P46060; P49792; P63279;
3uip20-97
Structure of human Senp2 in complex with SUMO-1 Heteromer
Q9HC62;
10×SO4;1tgz20-97
Crystal structure of human SENP1 mutant (C603S) in complex with SUMO-1 Heteromer
Q9P0U3;
2g4d20-97
Crystal structure of the human SENP2 C548S in complex with the human SUMO1 K48M F66W Heteromer
Q9HC62;
5aek20-97
Crystal structure of a complex between UBC9, SUMO-1, RANGAP1 and NUP358/RANBP2 Heteromer
P46060; P49792; P63279;
1z5s20-97
Molecular Determinants of Paralogue-Specific SUMO-SIM Recognition Heteromer
P49792;
2las20-97
Non-covalent complex between Ubc9 and SUMO1 Heteromer
P63280;
NA;2uyz20-96
Crystal structure of K46-acetylated SUMO1 in complex with phosphorylated PML-SIM Heteromer
P29590;
6uyv18-94
Crystal Structure of SUMO1 in complex with PML Heteromer
P29590;
4wjo18-94
Crystal structure of SUMO1 in complex with phosphorylated PML Heteromer
P29590;
4wjn18-94
Crystal structure of SUMO modified ubiquitin conjugating enzyme E2- 25K Heteromer
P61085;
2bf821-97
Human SUMO E1~SUMO1-AMP tetrahedral intermediate mimic Heteromer
Q9UBE0; Q9UBT2;
EDO;ZN;VMX;3kyd20-96
Complex of SUMO1 and phosphorylated hcmv protein IE2 Heteromer
P19893;
6k5t21-97
SUMO1 bound to SLS4-SIM peptide from ICP0 Heteromer
P08393;
6jxu21-97
Solution Structure of SUMO-1 in Complex with a SUMO-binding Motif (SBM) Heteromer
O75928;
2asq21-97
SUMO1 bound to phosphorylated SLS4-SIM peptide from ICP0 Heteromer
P08393;
6jxv21-97
Crystal structure of K37-acetylated SUMO1 in complex with phosphorylated PML-SIM Heteromer
P29590;
SEP;6uys19-94
SENP1 (mutant) SUMO1 RanGAP Heteromer
P46060; Q9P0U3;
2iy022-97
Crystal structure of K46-acetylated SUMO1 in complex with PML-SIM Heteromer
P29590;
6uyr19-93
Crystal structure of K39-acetylated SUMO1 in complex with PML-SIM Heteromer
P29590;
6uyp19-93
Crystal structure of K45-acetylated SUMO1 in complex with PML-SIM Heteromer
P29590;
6uyq19-93
Crystal structure of K37-acetylated SUMO1 in complex with PML-SIM Heteromer
P29590;
6uyo19-93
Crystal structure of K39-acetylated SUMO1 in complex with phosphorylated PML-SIM Heteromer
P29590;
6uyt19-93
Isoform-specific inhibition of SUMO-dependent protein-protein interactions Heteromer
5elj19-93
Crystal Structure of the Monobody ySMB-9 bound to human SUMO1 Heteromer
GOL;3rzw20-94
Crystal structure of human Senp2 in complex with RanGAP1-SUMO-1 Heteromer
P46060; Q9HC62;
2io223-97
Non-covalent complex between human SUMO-1 and human Ubc9 Heteromer
P63279;
2pe621-94
DPP8 - SLRFLYEG, space group 20 Heteromer
Q6V1X1;
FLC;CA;F15;6eop61-68
DPP8 - SLRFLYEG, space group 19 Heteromer
Q6V1X1;
6eot61-68
STRUCTURE DETERMINATION OF THE SMALL UBIQUITIN-RELATED MODIFIER SUMO-1, NMR, 10 STRUCTURESmonomer 1a5r1-101
Solution structure of human SUMO1monomer 2n1v1-97
Backbone fold of Human Small Ubiquitin like Modifier protein-1 (SUMO-1) based on Prot3D-NMR approac…monomer 2mw51-97
SOLUTION STRUCTURE OF LYS39 ACETYLATED HUMAN SUMO1monomer 5ghd1-97
SOLUTION STRUCTURE OF LYS37 ACETYLATED HUMAN SUMO1monomer 5b7a1-97
A conserved and buried edge-to-face aromatic interaction in SUMO is vital for the SUMO pathwaymonomer 6j4i1-97
Crystal structure of K46-acetylated SUMO1 in complex with phosphorylated DAXXmonomer SEP;6uyz17-95
Crystal structure of K39-acetylated SUMO1 in complex with phosphorylated DAXXmonomer 6uyy19-97
Crystal structure of K37-acetylated SUMO1 in complex with phosphorylated DAXXmonomer SEP;6uyx19-97
Crystal Structure of SUMO1 in complex with phosphorylated Daxxmonomer 4wjp19-97
Crystal Structure of SUMO1 in complex with Daxxmonomer 4wjq20-97
Crystal structure of SUMO1 in complex with phosphorylated PIAS-SIM2monomer 6v7q17-93
Crystal structure of SUMO1 in complex with PIAS-SIM2monomer 6v7p20-95
Crystal structure of K37-acetylated SUMO1 in complex with PIAS-SIM2monomer 6v7r20-93
Crystal structure of K37-acetylated SUMO1 in complex with phosphorylated PIAS-SIM2monomer 6v7s21-93
Crystal structure of HERC2 ZZ domain in complex with SUMO1 tailmonomer ZN;PEG;6ww32-7

Homology models built on isoform sequence

Isoform #Oligo-stateLigandsQMEANTemplateRangeSeq id (%)ReportDownloadAssess
2monomer-5.022n1a.1.A2-76
97.33